ASTELIN
Live / Allowed — First extension granted (statement of use) (as of 01 Jun 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 06 Jun 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98588595
- Mark type
- Word mark
- Filed
- 06 Jun 2024
- Published for opposition
- 07 Oct 2025
Goods and services
- Class 005 — Pharmaceuticals: Antihistamines
Owner
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
- Rising Pharma Holdings, Inc., East Brunswick, NJ, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 02 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2026 — SOU EXTENSION 1 GRANTED
- 01 Jun 2026 — SOU EXTENSION 1 FILED
- 01 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 29 Apr 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Apr 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Apr 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 Apr 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 Apr 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Dec 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Oct 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Oct 2025 — PUBLISHED FOR OPPOSITION
- 01 Oct 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED